Address |
333 Allerton Avenue San Francisco California 94080 United States |
Employees | - |
Website | http://www.myokardia.com |
Updated | 07/08/2019 |
MyoKardia, Inc. operates as a biopharmaceutical company. It engages in the discovery, development, and commercialization of targeted therapies for the treatment of cardiovascular diseases. The firm focuses on the treatment of heritable cardiomyopathies, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. |